论文部分内容阅读
目的探讨β受体阻滞剂治疗心力衰竭的临床效果。方法回顾性分析2013年6月至2015年6月68例心力衰竭患者的临床资料。按照治疗药物的不同将所有患者分为对照组和观察组各34例。观察两组患者治疗前后心率(HR)、收缩压(SBP)及左室射血分数(LVEF)3项指标的变化情况并进行疗效判定,随访6个月,统计两组患者再入院率。结果观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05)。观察组HR、SBP及LVEF改善情况均优于对照组,差异有统计学意义(P<0.05)。随访6个月,观察组再入院率低于对照组,差异有统计学意义(P<0.05)。结论β受体阻滞剂在心力衰竭的临床治疗中能改善心功能,延缓患者病情的发展,提高治疗效果,值得推广。
Objective To investigate the clinical effect of β-blocker on heart failure. Methods The clinical data of 68 patients with heart failure from June 2013 to June 2015 were retrospectively analyzed. According to the different therapeutic drugs, all patients were divided into control group and observation group, 34 cases each. The changes of heart rate (HR), systolic blood pressure (SBP) and left ventricular ejection fraction (LVEF) in two groups before and after treatment were observed and evaluated. The follow-up was 6 months, and the readmission rates of two groups were also calculated. Results The total effective rate of observation group was higher than that of control group, the difference was statistically significant (P <0.05). The improvement of HR, SBP and LVEF in observation group were better than that in control group, the difference was statistically significant (P <0.05). After 6 months of follow-up, the readmission rate of the observation group was lower than that of the control group (P <0.05). Conclusion β-blockers can improve cardiac function, delay the development of patients’ condition and improve the therapeutic effect in the clinical treatment of heart failure, which is worthy of popularization.